DK2117525T3 - Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte - Google Patents

Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte

Info

Publication number
DK2117525T3
DK2117525T3 DK08716394.5T DK08716394T DK2117525T3 DK 2117525 T3 DK2117525 T3 DK 2117525T3 DK 08716394 T DK08716394 T DK 08716394T DK 2117525 T3 DK2117525 T3 DK 2117525T3
Authority
DK
Denmark
Prior art keywords
dimethylamino
phenyl
treatment
neuropathic pain
propane compounds
Prior art date
Application number
DK08716394.5T
Other languages
English (en)
Inventor
Thomas Christoph
Babette-Yvonne Koegel
Elmar Friderichs
Muriel Dr Meen
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39345501&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2117525(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK2117525T3 publication Critical patent/DK2117525T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK08716394.5T 2007-03-12 2008-03-10 Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte DK2117525T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007012165A DE102007012165A1 (de) 2007-03-12 2007-03-12 Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
PCT/EP2008/001884 WO2008110323A1 (de) 2007-03-12 2008-03-10 Verwendung von 1-phenyl-3-dimethylamino-propanverbindungen zur therapie des neuropathieschmerzes

Publications (1)

Publication Number Publication Date
DK2117525T3 true DK2117525T3 (da) 2014-02-03

Family

ID=39345501

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08716394.5T DK2117525T3 (da) 2007-03-12 2008-03-10 Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte

Country Status (13)

Country Link
US (2) US20080269326A1 (da)
EP (1) EP2117525B1 (da)
JP (5) JP2010520907A (da)
CA (1) CA2680771C (da)
CY (1) CY1115455T1 (da)
DE (1) DE102007012165A1 (da)
DK (1) DK2117525T3 (da)
ES (1) ES2452830T3 (da)
HR (1) HRP20140280T1 (da)
PL (1) PL2117525T3 (da)
PT (1) PT2117525E (da)
SI (1) SI2117525T1 (da)
WO (1) WO2008110323A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012014482A (es) 2010-06-15 2013-02-21 Gruenenthal Gmbh Combinacion farmaceutica.
LT3650439T (lt) * 2010-07-23 2021-03-25 Grünenthal GmbH 3-(3-dimetilamino-1-etil-2-metil-propil)-fenolio druskos arba bendri kristalai
WO2012051246A1 (en) 2010-10-12 2012-04-19 Ratiopharm Gmbh Tapentadol hydrobromide and crystalline forms thereof
JP2019142972A (ja) * 2011-03-04 2019-08-29 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールの非経口的投与
CA2828631C (en) * 2011-03-04 2019-10-15 Grunenthal Gmbh Aqueous pharmaceutical formulation of tapentadol for oral administration
WO2012119728A1 (en) * 2011-03-04 2012-09-13 Grünenthal GmbH Parenteral administration of tapentadol
CA2828637C (en) 2011-03-04 2019-06-11 Grunenthal Gmbh Semisolid aqueous pharmaceutical composition containing tapentadol
PL2694049T3 (pl) 2011-04-05 2019-07-31 Grünenthal GmbH Tapentadol do zapobiegania przechodzeniu bólu w stan przewlekły
JP6040219B2 (ja) * 2011-04-05 2016-12-07 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 三叉神経因性痛に伴う疼痛の治療用タペンタドール
WO2012146383A1 (en) 2011-04-29 2012-11-01 Grünenthal GmbH Tapentadol for preventing and treating depression and anxiety
NO2736501T3 (da) 2011-07-29 2018-05-19
WO2013016840A1 (zh) 2011-07-29 2013-02-07 安徽省新星药物开发有限责任公司 用于合成他喷他多或其类似物的新中间体
CN103159633B (zh) * 2012-07-06 2015-08-12 江苏恩华药业股份有限公司 他喷他多的制备方法及用于制备他喷他多的化合物
EP2808319A1 (en) 2013-05-31 2014-12-03 Arevipharma GmbH 3-[3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex
PT3273953T (pt) 2015-03-27 2019-04-01 Gruenenthal Gmbh Formulação estável para administração parentérica de tapentadol
PE20190908A1 (es) 2016-09-23 2019-06-26 Gruenenthal Chemie Formulacion estable para la administracion parenteral de tapentadol
EP3585370A1 (en) 2017-02-23 2020-01-01 Grünenthal GmbH Tapentadol as local anesthetic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
EP3662904A1 (de) * 2002-11-22 2020-06-10 Grünenthal GmbH (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol zur behandlung von entzündungsschmerz
EP2012764B1 (en) * 2006-04-28 2011-01-12 Grünenthal GmbH Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol

Also Published As

Publication number Publication date
CY1115455T1 (el) 2017-01-04
WO2008110323A1 (de) 2008-09-18
JP2019196405A (ja) 2019-11-14
ES2452830T3 (es) 2014-04-02
JP2010520907A (ja) 2010-06-17
PT2117525E (pt) 2014-02-14
US8536130B2 (en) 2013-09-17
SI2117525T1 (sl) 2014-03-31
JP6745959B2 (ja) 2020-08-26
PL2117525T3 (pl) 2014-05-30
JP6081337B2 (ja) 2017-02-15
JP2013256540A (ja) 2013-12-26
CA2680771C (en) 2015-11-17
US20080269326A1 (en) 2008-10-30
DE102007012165A1 (de) 2008-09-18
JP2016056188A (ja) 2016-04-21
HRP20140280T1 (hr) 2014-04-25
CA2680771A1 (en) 2008-09-18
JP2018030886A (ja) 2018-03-01
EP2117525B1 (de) 2013-12-25
US20100311842A1 (en) 2010-12-09
EP2117525A1 (de) 2009-11-18

Similar Documents

Publication Publication Date Title
DK2117525T3 (da) Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte
DK3289876T3 (da) Forbindelser til behandling af cancer
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
DK2240130T3 (da) Indretning til behandling af fedme
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
DK3354276T3 (da) Sammensætninger til behandlingen af gastrointestinal inflammation
DK2307042T3 (da) Modulering af trpv: vps10p-domænereceptorsystem til behandlingen af smerte
DK1685834T3 (da) Anvendelse af pinolensyre til behandling af obesitet
DK2498771T3 (da) Anvendelse af bethanechol til behandling af xerostomi
DK2478907T3 (da) Sammensætninger til behandling af kræft
DK2500047T3 (da) Lægemiddelfrigivende coatinger til medicinske indretninger
BRPI0811265A2 (pt) Tratamento de sinucleinopatias
DK2346321T4 (da) Sammensætning til forbedring af effektiviteten af herbicider
DK2451482T3 (da) Kombinationsterapi til behandlingen af diabetes
DK2137537T3 (da) Sammensætninger og anvendelser til behandling af multipel sklerose
DK2209900T3 (da) Anvendelse af bakterier til fremstillingen af bioenergi
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
DK2047870T3 (da) Indretning til fotokatalytisk behandling af fluider
DK2167095T3 (da) Phenothiazin-forbindelser til behandling af let kognitiv svækkelse
DK2209784T3 (da) Forbindelser til behandling af hepatitis C
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
DK2114386T3 (da) Farmaceutisk sammensætning til behandling af diabeteskomplikationer
BRPI0820677A2 (pt) Misturas de compostos pesticidas
DK1838318T3 (da) Anvendelse af oxycodon til behandling af visceral smerte
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme